For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Ideaya Biosciences Inc’s stock clocked out at $16.98, down -0.76% from its previous closing price of $17.11. In other words, the price has decreased by -$0.76 from its previous closing price. On the day, 1.07 million shares were traded. IDYA stock price reached its highest trading level at $17.22 during the session, while it also had its lowest trading level at $16.665.
Ratios:
To gain a deeper understanding of IDYA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.97 and its Current Ratio is at 14.97. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 18, 2024, initiated with a Overweight rating and assigned the stock a target price of $51.
On November 05, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $27.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $50.UBS initiated its Buy rating on October 24, 2024, with a $50 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 26 ’24 when Jason Throne bought 75,000 shares for $40.22 per share.
WHITE MICHAEL ANTHONY sold 28,500 shares of IDYA for $1,032,884 on May 29 ’24. The Chief Scientific Officer now owns 0 shares after completing the transaction at $36.24 per share. On May 15 ’24, another insider, Hata Yujiro S, who serves as the President and CEO of the company, sold 83,856 shares for $42.90 each. As a result, the insider received 3,597,756 and left with 677,887 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 1486385024 and an Enterprise Value of 829236928. For the stock, the TTM Price-to-Sale (P/S) ratio is 212.34 while its Price-to-Book (P/B) ratio in mrq is 1.39. Its current Enterprise Value per Revenue stands at 118.462 whereas that against EBITDA is -2.555.
Stock Price History:
The Beta on a monthly basis for IDYA is 0.27, which has changed by -0.5772965 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, IDYA has reached a high of $44.42, while it has fallen to a 52-week low of $13.45. The 50-Day Moving Average of the stock is -10.64%, while the 200-Day Moving Average is calculated to be -40.69%.
Shares Statistics:
It appears that IDYA traded 1.12M shares on average per day over the past three months and 2019160 shares per day over the past ten days. A total of 86.50M shares are outstanding, with a floating share count of 80.84M. Insiders hold about 7.65% of the company’s shares, while institutions hold 100.87% stake in the company. Shares short for IDYA as of 1743379200 were 9945435 with a Short Ratio of 8.89, compared to 1740700800 on 9188885. Therefore, it implies a Short% of Shares Outstanding of 9945435 and a Short% of Float of 12.65.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
